Source: The Business Journals

Kurome Therapeutics: Kurome Therapeutics lands 'milestone' FDA clearance for novel leukemia treatment

A Hyde Park-based startup spun-out of Cincinnati Children's Hospital in 2019 has cleared its first major hurdle with the U.S. Food and Drug Administration.

Read full article »

Kurome Therapeutics's Competitors | Kurome Therapeutics's News | Kurome Therapeutics's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Jan Rosenbaum

CEO Approval Rating

90/100

Kurome Therapeutics is an Ohio-based preclinical stage biotechnology company that researches and develops novel therapeutics for the treatment of cancer.